Jiang; Zhigan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Jiang; Zhigan.The latest application filed is for "salt and crystal form of modified andrographolide compound and preparation method thereof".

Company Profile

13.12.16

Jiang; Zhigan - Shanghai CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Amorphous pyrrolidine derivative as PPAR agonist and preparation method thereof Grant 11,396,493 - Yuan , et al. July 26, 2	2022-07-26
Salt and crystal form of modified andrographolide compound and preparation method thereof Grant 11,299,482 - Xia , et al. April 12, 2	2022-04-12
Salt And Crystal Form Of Modified Andrographolide Compound And Preparation Method Thereof App 20210284630 - XIA; Jianhua ; et al.	2021-09-16
Crystal Forms Of Thiazole Compound And Application Thereof App 20210276993 - SHI; Weihua ; et al.	2021-09-09
Thieno[2,3-c]pyridazin-4(1h)-one Derivative And Application Thereof App 20210238190 - ZHENG; Xiaoping ; et al.	2021-08-05
Crystal Form Of Tri-cycle Compound And Application Thereof App 20210230188 - WANG; Jing ; et al.	2021-07-29
Tri-cycle compound and applications thereof Grant 11,053,260 - He , et al. July 6, 2	2021-07-06
Process for preparing 1-isobutyryl-1'-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo[D]- imidazol-2-yl)methyl)spiro[azetidine-3,3'-indolin]-2'-one Grant 10,858,322 - Shi , et al. December 8, 2	2020-12-08
Amorphous Pyrrolidine Derivative As Ppar Agonist And Preparation Method Thereof App 20200339508 - Yuan; Zhiliang ; et al.	2020-10-29
Tri-cycle Compound And Applications Thereof App 20200247819 - Kind Code	2020-08-06
Modified compound of andrographolide Grant 10,717,720 - He , et al.	2020-07-21
Process For Preparing 1-isobutyryl-1'-((1-(4,4,4-trifluoro-butyl)-4,5,6,7- Tetrahydro-1h-benzo[d]imidazol-2-yl)methyl)spiro[azet App 20200223802 - SHI; Weihua ; et al.	2020-07-16
Thiazole derivative and applications thereof Grant 10,647,710 - He , et al.	2020-05-12
Crystal form B of 1-isobutyryl-1'-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo[d]- imidazol-2-yl)methyl)spiro[azetidine-3,3'-indolin]-2'-one Grant 10,633,347 - Shi , et al.	2020-04-28
Pyrrolidine derivatives as PPAR agonists Grant 10,526,320 - Yuan , et al. J	2020-01-07
Thiazole Derivative And Applications Thereof App 20190375744 - He; Haiying ; et al.	2019-12-12
Pyrrolidine Derivatives As Ppar Agonists App 20190225597 - Yuan; Zhiliang ; et al.	2019-07-25
Crystal Form A Of 1-isobutyryl-1'-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1h-benzo[d]- Imidazol-2-yl)methyl)spiro[azetidin App 20190218189 - SHI; Weihua ; et al.	2019-07-18
Crystal form A of 1-isobutyryl-1'-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo [d]imidazol-2-yl)methyl)spiro[azetidine-3,3'-indolin]-2'-one Grant 10,227,309 - Shi , et al.	2019-03-12
Quinolone derivatives as antibacterials Grant 10,160,726 - Fidalgo , et al. Dec	2018-12-25
Modified Compound Of Andrographolide App 20180346438 - HE; Haiying ; et al.	2018-12-06
Imidazole derivative used as antiviral agent and use thereof in preparation of medicament Grant 10,030,029 - He , et al. July 24, 2	2018-07-24
Method For Preparing Imidazole Derivative And Intermediate Thereof And Crystal Form App 20180141915 - SHI; Weihua ; et al.	2018-05-24
Imidazole Derivative Used As Antiviral Agent And Use Thereof In Preparation Of Medicament App 20180009820 - He; Haiying ; et al.	2018-01-11
Imidazole derivative used as antiviral agent and use therof in preparation of medicament Grant 9,850,251 - He , et al. December 26, 2	2017-12-26
Quinolone Derivatives As Antibacterials App 20170217897 - FIDALGO; Javier de Vicente ; et al.	2017-08-03
Imidazole Derivative Used As Antiviral Agent And Use Therof In Preparation Of Medicament App 20160318943 - He; Haiying ; et al.	2016-11-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.